Promise of Precision Medicine in Cancers: Lessons Learned.
作者信息
Dey Nandini, Williams Casey, Leyland-Jones Brian, De Pradip
机构信息
Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, South Dakota.
Department of Internal Medicine,University of South Dakota Sanford School of Medicine.
出版信息
S D Med. 2017 Nov;70(11):486-490.
PMID:29088519
Abstract
摘要
相似文献
1
Promise of Precision Medicine in Cancers: Lessons Learned.癌症精准医学的前景：经验教训
S D Med. 2017 Nov;70(11):486-490.
2
Precision medicine: lessons learned from the SHIVA trial.精准医学：从SHIVA试验中汲取的经验教训。
Lancet Oncol. 2015 Dec;16(16):e580. doi: 10.1016/S1470-2045(15)00387-3.
3
Precision medicine: lessons learned from the SHIVA trial.精准医学：从SHIVA试验中汲取的经验教训。
Lancet Oncol. 2015 Dec;16(16):e580-1. doi: 10.1016/S1470-2045(15)00458-1.
4
Precision medicine: lessons learned from the SHIVA trial.精准医学：从SHIVA试验中吸取的教训。
Lancet Oncol. 2015 Dec;16(16):e579-80. doi: 10.1016/S1470-2045(15)00397-6.
5
Precision medicine: lessons learned from the SHIVA trial - Authors' reply.精准医学：从SHIVA试验中汲取的经验教训——作者回复
Lancet Oncol. 2015 Dec;16(16):e581-2. doi: 10.1016/S1470-2045(15)00455-6.
6
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.从莫菲特分子肿瘤委员会吸取的关键经验教训：临床基因组学行动委员会的经验。
Oncologist. 2017 Feb;22(2):144-151. doi: 10.1634/theoncologist.2016-0195. Epub 2017 Feb 8.
7
Implementation of Precision Cancer Medicine: Progress and the Path to Realizing the Promise of Tumor Sequencing.精准癌症医学的实施：进展与实现肿瘤测序前景的途径
J Oncol Pract. 2019 Jun;15(6):297-299. doi: 10.1200/JOP.19.00176. Epub 2019 May 21.
8
Delivering on the promise of precision cancer medicine.兑现精准癌症医学的承诺。
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
9
Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.临床蛋白质组学驱动的精准癌症靶向治疗：当前概述与未来展望
Expert Rev Proteomics. 2016;13(4):367-81. doi: 10.1586/14789450.2016.1159959. Epub 2016 Mar 16.
10
[Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].[精准医学：在特定情况下向前迈出的一大步，在难治性癌症中是神话吗？]
Bull Cancer. 2018 Apr;105(4):375-396. doi: 10.1016/j.bulcan.2018.01.009. Epub 2018 Mar 1.
引用本文的文献
1
Decision making in precision oncology: an issue of mutational contextuality.精准肿瘤学中的决策制定：突变背景问题
Am J Cancer Res. 2019 Mar 1;9(3):628-629. eCollection 2019.
Zotero 插件